Badger 50 Mineral Sunscreen Recalled for Missing Drug Facts Labeling
The W.S. Badger Company is recalling Badger 50 mineral sunscreen tins lacking the complete drug facts label, barcode, and directions for use. The recall affects 4,834 tins distributed nationwide.
What this means for you
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: This is a Class III FDA recall for missing labeling and documentation with no reported illnesses or injuries. Per the rubric, labeling errors and documentation issues without reported harm are classified as Moderate (Score 2).
Plain-English summary
The W.S. Badger Company is recalling Badger 50 mineral sunscreen (25% uncoated zinc oxide) in 2.4 oz. tins due to missing labeling. The affected product potentially lacks the complete drug facts label panel, barcode, and directions for use.
Without proper labeling, consumers cannot access the drug facts information or directions for safe and proper use of the product.
The recall affects 4,834 tins distributed nationwide in the USA. The affected lot is LOT# 091923A with expiration date 09/19/26.
As of the recall notice, no illnesses or injuries have been reported in connection with this product.
The recalled product
- Product
- BADGER 50, ADVENTURE SPORT MINERAL SUNSCREEN WITH CLEAR ZINC, (uncoated 25% zinc oxide), 2.4 oz., Tin, W.S. Badger Company, Inc, 768 Route 10, Gilsum NH, 03448 UPC 6 34084 47150 2
- Manufacturer
- The W.S. Badger Company, Inc.
- Category
- Drug — Sunscreen
- Hazard
- missing-labeling
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (2)
- LOT# 091923A
- Exp. Date 09/19/26
Distribution
Distributed nationwide across the United States.
Related recalls
Same category
- CriticalWarfarin Tablets Recalled After Mix-Up Between 2.5 mg and 5 mg Strengths
FDA (Drugs) · 2026-07-21
- SevereErythromycin Tablets Recalled for Impurity Above Acceptable Limits
FDA (Drugs) · 2026-05-27
- SevereAtomoxetine Capsules Recalled Due to Labeling Mix-Up Error
FDA (Drugs) · 2026-05-27
- ModeratePrimidone Tablets Recalled Due to API Cross-Contamination
FDA (Drugs) · 2026-05-27
- SevereCIMZIA injection recalled due to lack of sterility assurance
FDA (Drugs) · 2026-05-27